Genentech’s Tanox Acquisition Delayed Due to FTC Information Request
This article was originally published in The Pink Sheet Daily
Executive Summary
Firms expect $919 million deal to close by mid-year.
You may also be interested in...
FDA Asks Genentech To Add Boxed Anaphylaxis Warning To Xolair Label
Continued post-marketing reports of anaphylaxis, some well after treatment, led agency to ask for label revision.
FDA Asks Genentech To Add Boxed Anaphylaxis Warning To Xolair Label
Continued post-marketing reports of anaphylaxis, some well after treatment, led agency to ask for label revision.
Genentech's Acquisition Of Tanox Does Not Represent A Strategic Shift, CEO Says
Genentech will continue to set a "high bar" for acquisitions after buying Xolair partner Tanox for $919 mil., firm says.